Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea
- Authors
- Park, Yongsoon; Park, Yoo-Sin; Kim, Seok Hyeon; Oh, Dong Hoon; Park, Yong-Chon
- Issue Date
- 2015
- Publisher
- KARGER
- Keywords
- Korean; Major depressive disorder; n-3 polyunsaturated fatty acid; Randomized placebo-controlled trial
- Citation
- ANNALS OF NUTRITION AND METABOLISM, v.66, no.2-3, pp.141 - 148
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANNALS OF NUTRITION AND METABOLISM
- Volume
- 66
- Number
- 2-3
- Start Page
- 141
- End Page
- 148
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/158301
- DOI
- 10.1159/000377640
- ISSN
- 0250-6807
- Abstract
- Background: Controversy over the efficacy of n-3 polyunsaturated fatty acids (PUFAs) in depression continues to this day. The present study investigated the hypothesis that n-3 PUFA supplementation reduces depressive symptoms in Korean patients with major depressive disorder. Methods: In a randomized, double-blind, placebo-controlled, 12-week, parallel-group trial, 35 patients with Center for Epidemiological Studies Depression Scale Korean version (CES-D-K) scores >= 25 and depression confirmed by a psychiatrist were assigned to take either 3 capsules of n-3 PUFAs (1,140 mg of EPA + 600 mg of DHA; n = 18) or placebo (olive oil + safflower oil; n = 17). Results: Supplementation with n-3 PUFAs significantly reduced Clinical Global Impression Improvement (CGI-I) scores as compared with intake of placebo using intention-to-treat analysis with last-observation-carried-forward after adjusting for energy, fat, and fish intake. However, the CES-D-K, Hamilton Depression Rating Scale-17, and Clinical Global Impression Scale scores did not significantly differ between the n-3 PUFA and placebo groups. After supplementation with n-3 PUFAs, the erythrocyte levels of n-3 PUFAs were significantly increased, but n-6 PUFA levels were decreased. Conclusions: n-3 PUFAs demonstrated an advantage over placebo that did not reach clinical significance, although CGI-I score was significantly decreased in the n-3 PUFA group as compared with the placebo group.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 정신건강의학교실 > 1. Journal Articles
- 서울 생활과학대학 > 서울 식품영양학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/158301)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.